Type 2 Diabetes patients prescribed Actos for long-term treatment are starting to flood into the court system with claims that Actos caused them to develop bladder cancer. In June of 2011, the FDA issued a warning to the public that the use of Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer. This new warning came about as a result of the FDA ...